摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3,5-diphenyl-1-pyrazolyl)-2-thiazoline | 1374869-21-2

中文名称
——
中文别名
——
英文名称
2-(3,5-diphenyl-1-pyrazolyl)-2-thiazoline
英文别名
2-(3,5-diphenylpyrazol-1-yl)-2-thiazoline;DPhPyTn
2-(3,5-diphenyl-1-pyrazolyl)-2-thiazoline化学式
CAS
1374869-21-2
化学式
C18H15N3S
mdl
——
分子量
305.403
InChiKey
ILNMBPVNRNETDX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.17
  • 重原子数:
    22.0
  • 可旋转键数:
    2.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    30.18
  • 氢给体数:
    0.0
  • 氢受体数:
    4.0

反应信息

  • 作为反应物:
    描述:
    sodium tetrachloropalladate(II) trihydrate 、 2-(3,5-diphenyl-1-pyrazolyl)-2-thiazoline乙醇 为溶剂, 以48.2 %的产率得到[PdCl2(2-(3,5-diphenyl-1-pyrazolyl)-2-thiazoline)]
    参考文献:
    名称:
    新型钯 (II) 与噻嗪或噻唑啉衍生物配体的配合物对肿瘤细胞系的细胞毒性作用。
    摘要:
    使用其他金属中心合成顺铂类似物可能成为癌症治疗的替代方案,顺铂是一种广泛使用的化疗剂。由于配位化学相似,Pd(II) 可以替代 Pt(II)。因此,本文合成并表征了六种具有噻嗪和噻唑啉配体的方形平面 Pd(II) 配合物,其结构式为 [PdCl2(L)]。通过细胞毒性测定,在三种不同的人类肿瘤细胞系(即上皮性宫颈癌(HeLa)、早幼粒细胞白血病(HL-60)和组织细胞淋巴瘤(U-937))中研究了这些化合物的潜在抗癌能力。获得的数据表明,具有甲基取代的复合物不会改变细胞活力,而无甲基取代的化合物对所有三种细胞系均具有中等的细胞毒性作用。具有苯基取代的复合物显示出最低的IC50值,其范围在46.39±3.99μM和62.74±6.45μM之间。此外,与上述四种复合物中的任何一种一起孵育后,观察到细胞内钯的积累,并且发现两种带有苯环的复合物可诱导凋亡细胞百分比的增加。这些结果表明,配体上存在大
    DOI:
    10.3390/pharmaceutics15020696
  • 作为产物:
    描述:
    3,5-二苯基吡唑异硫氰酸氯代乙酯 在 sodium hydride 作用下, 以 甲苯 、 mineral oil 为溶剂, 反应 7.0h, 以50.4%的产率得到2-(3,5-diphenyl-1-pyrazolyl)-2-thiazoline
    参考文献:
    名称:
    Influence of steric strain of S,N-heterocycles derivative ligands on the coordination geometry in cadmium(II) nitrato complexes
    摘要:
    The new ligands 2-(3,5-dimethyl-1-pyrazolyl)-2-thiazoline (DMPyTn) and 2-(3,5-diphenyl-1-pyrazolyl)-2-thiazoline (DPhPyTn) have been synthesized and characterized, and six cadmium(II) nitrato complexes with these two ligands and four other pyrazole/S,N-heterocyclic derivative ligands with different steric features, previously reported, have been prepared and structurally characterized by means of elemental analysis, single crystal X-ray diffraction and IR spectra, with the objective of determining the role played by the steric strains of the ligands on the metal ion coordination index and geometry. The effect of two factors has been analyzed: the bulk of the pyrazole ring substituents and the size of the S,N-heterocycle. The data indicate that there is a clear influence of the size of the organic ligands on the coordination environment of the Cd(II) ion. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.poly.2011.09.033
点击查看最新优质反应信息

文献信息

  • Influence of ligand lipophilicity in Pt(II) complexes on their antiproliferative and apoptotic activities in tumour cell lines
    作者:Elena Fernández-Delgado、Samuel Estirado、Javier Espino、Emilio Viñuelas-Zahínos、Francisco Luna-Giles、Ana B. Rodríguez Moratinos、José A. Pariente
    DOI:10.1016/j.jinorgbio.2021.111688
    日期:2022.2
    coordination of bioactive ligands to transition metals, which could improve biological activity. Moreover, the incorporation of aromatic groups to ligands may allow an enhanced lipophilicity that can influence the cellular uptake and accumulation of the metallodrugs, thus increasing their activity. Herein, we have reported the synthesis and characterization of four Pt(II) complexes [PtCl2(L)], where
    药物开发最广泛使用的策略之一是将生物活性配体与过渡属配位,这可以提高生物活性。此外,芳香基团与配体的结合可以提高亲脂性,从而影响属药物的细胞摄取和积累,从而提高它们的活性。在此,我们报道了四种 Pt(II) 配合物 [PtCl 2(L)],其中 L = 2-(1-吡唑基)-2-噻唑啉 (PzTn)、2-(1-吡唑基)-1,3-噻嗪 (PzTz)、2-(3,5-diphenyl-1 -吡唑基)-2-噻唑啉 (DPhPzTn) 或 2-(3,5-二苯基-1-吡唑基)-1,3-噻嗪 (DPhPzTz)。该研究旨在分析它们在上皮性宫颈癌HeLa、人早幼粒细胞白血病HL-60和人组织细胞淋巴瘤U-937肿瘤细胞系中的潜在抗癌能力,并检查有机配体的结构因素是否可能影响其生物活性。我们的研究结果表明,就细胞毒性而言,PtDPhPzTn 和 PtDPhPzTz 比它们的亲脂性较低的对应物(PtPzTn
  • Copper(II) halide coordination complexes with 2-(3,5-diphenyl-1-pyrazolyl)-2-thiazoline (DPhPyTn): Synthesis, characterization and crystal structures
    作者:A.V. Huertas-Sánchez、F. Luna-Giles、E. Viñuelas-Zahínos、F.J. Barros-García、A. Bernalte-García
    DOI:10.1016/j.poly.2015.10.013
    日期:2015.12
    Reactions between CuX2 (X = Cl, Br) and 2-(3,5-diphenyl-1-pyrazolyl)-2-thiazoline (DPhPyTn) yield the complexes [CuCl(DPhPyTn)}(2)(mu-Cl)(2)] (1), [CuBr(DPhPyTn)(2)]Br (2) and [CuBr(DPhPyTn)}(2)(mu-Br)(2)] (3). Copper(II) complexes have been characterized by elemental analysis, IR, electronic spectra, single crystal X-ray diffraction and magnetic susceptibility measurements. Likewise, the crystal structure of DPhPyTn has been determined. Complexes 1 and 3 are dimeric molecules in which copper ions are bridged by two halide anions whereas 2 is a monomeric unit. The geometry around the copper(II) center in the dimeric units is a distorted squared pyramid, while in the monomeric compound is a distorted trigonal bipyramid. The magnetic susceptibility data of dimeric compounds were followed by the Bleaney-Bowers dimer equation with J = -1.17 and -2.36 cm(-1) for the chloro and bromo complexes respectively, indicating that there are weak antiferromagnetic interactions between the copper(II) ions in the solid state. (C) 2015 Elsevier Ltd. All rights reserved.
  • Substituent’s size in pyrazole derivative ligands as determining factor on nuclearity in Cu(II) complexes
    作者:R. Pedrero-Marín、A.V. Sánchez-Huertas、F. Luna-Giles、F. De la Cruz-Martínez、E. Viñuelas-Zahínos
    DOI:10.1016/j.poly.2014.05.029
    日期:2014.9
查看更多